Test Price
2,800 AED✅ Home Collection Available
PDGFRA Gene Selective Sequencing of Exons 12, 14, and 18 (NGS) in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
🔬 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited Processing
Results generated on a validated NGS platform, adhering to the highest international standards and DHA/MOHAP regulatory frameworks.
🚚 VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection
A DHA-licensed phlebotomist visits your home, office, or hotel between 8 AM and 11 PM, using ISO-certified cold-chain transport. Whole blood, extracted DNA, or a single drop on an FTA card accepted.
📞 Telephonic Post-Test Clinical Guidance
Receive a one-on-one consultation with Consultant Medical Genetics Lina Osama Zaki Quteineh (DHA: 9294403) to interpret your results in a clinically meaningful context.
💳 Direct Insurance Billing
Verify coverage instantly via WhatsApp at +971 54 548 8731 – we process claims directly with all major UAE insurers.
Test Overview & Methodology
Comprehensive PDGFRA Mutation Analysis for GIST and Beyond
This Next-Generation Sequencing (NGS) test selectively screens exons 12, 14, and 18 of the PDGFRA gene, identifying clinically actionable mutations that drive gastrointestinal stromal tumors (GIST) and other malignancies.
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger Single Exon) |
|---|---|---|
| Method | Next-Generation Sequencing (NGS) – high coverage, simultaneous analysis of 3 critical exons | Sanger sequencing – one exon at a time, lower analytical sensitivity |
| Detection Sensitivity | 99.9% for exon 12, 14, 18 variants (including low-frequency mutations) | ~95% for high-quality samples, risk of missing low-level mosaicism |
| Turnaround Time | 3–4 weeks (comprehensive report with expert interpretation) | 2–3 weeks per exon (multiple sequential tests may be required) |
| Clinical Utility | Directly guides imatinib/sunitinib sensitivity; DHA/MOHAP-recognised | Limited to known hotspot regions; often requires reflex to NGS for complete picture |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I understand that pursuing genetic testing is a deeply personal step — it can bring clarity but also raise new questions. This PDGFRA analysis is a powerful tool for tailoring targeted therapy in GIST, yet it must always be correlated with your full clinical and family history. My team and I are committed to walking this path with you, ensuring every result is translated into a clear, compassionate care plan.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
Do not discontinue any prescribed medication, including tyrosine kinase inhibitors (e.g., imatinib), without explicit direction from your treating oncologist. Genetic test results are one piece of a larger clinical puzzle and must be integrated into a comprehensive treatment plan.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide legally valid informed consent; minors without consent from a legal guardian as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Exclusion: No established clinical suspicion for GIST or PDGFRA-related malignancy — testing is medically indicated for diagnostic and therapeutic decisions.
- Exclusion: Recent allogeneic blood transfusion or bone marrow transplant that may confound germline analysis (wait 4 weeks).
- ER Red Flag: Sudden, severe abdominal pain, gastrointestinal bleeding, or an acute mass effect — seek immediate emergency care irrespective of genetic test status.
- ER Red Flag: Severe psychological distress triggered by the testing process — contact your healthcare provider or emergency services.
Patient FAQ & Clinical Guidance
1. How long does it take to receive PDGFRA exon 12, 14, 18 NGS results in the UAE?
Your comprehensive report is delivered within 3 to 4 weeks after sample collection, including a detailed clinical interpretation by Consultant Medical Genetics Lina Osama Zaki Quteineh.
2. Can I use my health insurance to cover this test?
Yes, we verify direct billing eligibility with all major UAE insurers via WhatsApp at +971 54 548 8731 before scheduling your home collection.
3. Is a single drop of blood on an FTA card sufficient for NGS analysis?
Absolutely, our laboratory accepts whole blood, extracted DNA, or a single dried blood spot on an FTA card, all processed with equal diagnostic accuracy.
UAE Regulatory & Data Privacy Adherence
Your Privacy and Safety are Legally Protected
This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic data is stored and processed solely within the UAE under the highest standards of confidentiality and security. Our facility is ISO 9001:2015 certified and operates under DHA Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | PDGFRA Gene Selective Sequencing of Exons 12, 14, and 18 (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood, Extracted DNA, or FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | C49.A (Gastrointestinal stromal tumor) |
| LOINC Code | 93223-7 (PDGFRA gene targeted mutation analysis) |
| DHA Facility License & Address | License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians